Evidence map›Paper›PMID 39543652›Full record

ArticleJournal of cheminformatics2024

QSPRpred: a Flexible Open-Source Quantitative Structure-Property Relationship Modelling Tool.

Helle W van den Maagdenberg, Martin Šícho, David Alencar Araripe, Sohvi Luukkonen, Linde Schoenmaker, Michiel Jespers, Olivier J M Béquignon, Marina Gorostiola González, Remco L van den Broek, Andrius Bernatavicius and 3 more

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Fingerprint-Based Machine Learning for SARS-CoV-2 and MERS-CoVJournal of chemical information and modeling · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Helle W van den Maagdenberg *Computational Drug Discovery, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, Leiden, 2333 CC, The Netherlands.ORCID https://orcid.org/0000-0002-9718-7806
Martin Šícho *Computational Drug Discovery, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, Leiden, 2333 CC, The Netherlands.ORCID https://orcid.org/0000-0002-8771-1731
David Alencar AraripeComputational Drug Discovery, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, Leiden, 2333 CC, The Netherlands.ORCID https://orcid.org/0000-0002-5104-1959
Sohvi LuukkonenComputational Drug Discovery, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, Leiden, 2333 CC, The Netherlands.ORCID https://orcid.org/0000-0001-9387-1427
Linde SchoenmakerComputational Drug Discovery, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, Leiden, 2333 CC, The Netherlands.ORCID https://orcid.org/0000-0001-9879-1004
Michiel JespersComputational Drug Discovery, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, Leiden, 2333 CC, The Netherlands.ORCID https://orcid.org/0009-0003-2083-0159
Olivier J M BéquignonComputational Drug Discovery, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, Leiden, 2333 CC, The Netherlands.ORCID https://orcid.org/0000-0002-7554-9220
Marina Gorostiola GonzálezComputational Drug Discovery, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, Leiden, 2333 CC, The Netherlands.ORCID https://orcid.org/0000-0003-1568-0881
Remco L van den BroekComputational Drug Discovery, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, Leiden, 2333 CC, The Netherlands.ORCID https://orcid.org/0009-0008-5661-1157
Andrius BernataviciusComputational Drug Discovery, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, Leiden, 2333 CC, The Netherlands.ORCID https://orcid.org/0000-0002-0058-3678
J G Coen van HasseltComputational Drug Discovery, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, Leiden, 2333 CC, The Netherlands.ORCID https://orcid.org/0000-0002-1664-7314
Piet H van der GraafComputational Drug Discovery, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, Leiden, 2333 CC, The Netherlands.ORCID https://orcid.org/0000-0003-1314-3484
Gerard J P van WestenComputational Drug Discovery, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, Leiden, 2333 CC, The Netherlands. gerard@lacdr.leidenuniv.nl.ORCID https://orcid.org/0000-0003-0717-1817

Funding

Czech Science Foundation Grant 22-17367ODutch National Growth Fund NGFOP2201HORIZON EUROPE Marie Sklodowska-Curie Actions 955879Ministry of Education, Youth and Sports of the Czech Republic LM2023052
6 · The paper itself

Abstract

Building reliable and robust quantitative structure-property relationship (QSPR) models is a challenging task. First, the experimental data needs to be obtained, analyzed and curated. Second, the number of available methods is continuously growing and evaluating different algorithms and methodologies can be arduous. Finally, the last hurdle that researchers face is to ensure the reproducibility of their models and facilitate their transferability into practice. In this work, we introduce QSPRpred, a toolkit for analysis of bioactivity data sets and QSPR modelling, which attempts to address the aforementioned challenges. QSPRpred's modular Python API enables users to intuitively describe different parts of a modelling workflow using a plethora of pre-implemented components, but also integrates customized implementations in a "plug-and-play" manner. QSPRpred data sets and models are directly serializable, which means they can be readily reproduced and put into operation after training as the models are saved with all required data pre-processing steps to make predictions on new compounds directly from SMILES strings. The general-purpose character of QSPRpred is also demonstrated by inclusion of support for multi-task and proteochemometric modelling. The package is extensively documented and comes with a large collection of tutorials to help new users. In this paper, we describe all of QSPRpred's functionalities and also conduct a small benchmarking case study to illustrate how different components can be leveraged to compare a diverse set of models. QSPRpred is fully open-source and available at https://github.com/CDDLeiden/QSPRpred .Scientific ContributionQSPRpred aims to provide a complex, but comprehensive Python API to conduct all tasks encountered in QSPR modelling from data preparation and analysis to model creation and model deployment. In contrast to similar packages, QSPRpred offers a wider and more exhaustive range of capabilities and integrations with many popular packages that also go beyond QSPR modelling. A significant contribution of QSPRpred is also in its automated and highly standardized serialization scheme, which significantly improves reproducibility and transferability of models.

Indexed as

CheminformaticsMachine learningProteochemometricsQSAR modellingQSPR modellingSoftware

Identifiers

PMID39543652
PMCPMC11566221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.